Clinical Trial Update: Immunogenicity and Safety of Gardasil-9 and Cervarix [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting on the immunogenicity and safety of Gardasil-9 and Cervarix HPV vaccines.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Cervical Cancer
• Genital Warts
• Human Papillomavirus Infection
• Oropharyngeal Cancer
• Penile Cancer
• Vulvar Cancer

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)
• Gardasil 9 (Human papillomavirus vaccine, 9-valent)

Snippet

Sponsor: Laval University | Conditions: HPV Vaccines Immunogenicity and Safety | Phase 3 | Status: COMPLETED